The 26 references in paper I. Yegorova N., A. Vlasenko V., V. Moroz V., V. Yakovlev N., V. Alekseyev G., И. Егорова Н., А. Власенко В., В. Мороз В, В. Яковлев Н., В. Алексеев Г. (2010) “Вентилятор-ассоциированная пневмония: диагностика, профилактика, лечение (cовременное состояние вопроса) // Ventilator-Associated Pneumonia: Diagnosis, Prevention, Treatment (State-of-the-Art of the Problem)” / spz:neicon:reanimatology:511

1
Rello J., Ollendorf D. A., Oster G. et al.Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002, 122 (6): 2115—2121.
(check this in PDF content)
2
Niederman M. S., Craven D. E., Fein A. M. et al.Pneumonia in the critically ill hospitalised patient. Chest 1990; 97 (1): 170—181.
(check this in PDF content)
3
Pingleton S. K., Fagon J. Y., Leeper K. V. Patient selection for clinical investigation of ventilator-associated pneumonia. Criteria for evaluating diagnostic techniques. Chest. 1992; 102 (5 Suppl 1): 553S—556S.
(check this in PDF content)
4
Light R.B.Ventilator associated pneumonia: asking the right question. Thorax 1999; 54 (10): 863—864.
(check this in PDF content)
5
Rello J., Ausina V., Ricart M. et al.Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104 (4): 1230—1235.
(check this in PDF content)
6
Rello J., Quintana E., Ausina V. et al.Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients, Chest 1991; 100 (2): 439—444.
(check this in PDF content)
7
Heyland D. K., Cook D. J., Griffith L. et al. The atributable morbitidy and mortality of ventilator associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am. J. Respir. Crit. Care Med. 1999, 159 (4 Pt 1): 1249—1256.
(check this in PDF content)
8
National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990 — May 1999, issue June 1999. An. J. Infect. Control 1999; 27: 520—532.
(check this in PDF content)
9
Fagon J. Y., Chastre J., Hance A. J. et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Amer. J. Med. 1993; 94 (3): 281—288.
(check this in PDF content)
10
Яковлев С. В.Госпитальные пневмонии вопросы диагностики и антибактериальной терапии Consilium medicum 2000, 2, 400—404.
(check this in PDF content)
11
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 2005, 171 (4): 388—416.
(check this in PDF content)
12
Bagshaw S. M., Laupland K. B.Epidemiology of intensive care unitacquired urinary tract infections. Curr. Opin. Infect. Dis. 2006; 19 (1): 67—71.
(check this in PDF content)
13
Гельфанд Б. Р., Гологорский В. А., Белоцерковский Б. З. и соавт.Нозокомиальная пневмония, связанная с ИВЛ у хирургических больных. М.; 2000.
(check this in PDF content)
14
Белобородова Н. В.Бактериемия и сепсис. Пособие для врачей «Инфекция в стационаре». М.; 2008.
(check this in PDF content)
15
Grigoriu B., Jacobs F., Beuzen F. et al.Bronchoalveolar lavage cytological alveolar damage in patients with severe pneumonia. Crit. Care 2006; 10 (1): R2.
(check this in PDF content)
16
Chastre J., Fagon J. Y., Soler P. et al. Diagnosis of nosocomial bacterial pneumonia in intubated undergoing ventilation: comparison of the usefulness of bronchoalveolar lavage and protected specimen brush. Amer. J. Med. 1988; 85 (4): 499—506.
(check this in PDF content)
17
Russwurms S., Wiederhold W., Oberhoffer M. et al.Procalcitonin as a monocyte marker for early diagnosis in septic abortus (in German). Z. Geburtsh Neonatal. 1999; 14: 29—33.
(check this in PDF content)
18
Nijsten M. W., Olinga P., de Vries E. G. et al. Procalcitonin behaves as a fast responding acute phase protein in vivoandin vitro.Crit. Сare Med. 2000; 28 (2): 458-461.
(check this in PDF content)
19
Christ-Crain M., Jaccard-Stolz D., Bingisser R. et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004; 363 (9409): 600—607
(check this in PDF content)
20
Lowy F. D., Carlisle P. S., Adams A., Feiner C.The incidence of nosocomial pneumonia following urgent endotracheal intubation. Infect. Control 1987; 8 (6): 245—248.
(check this in PDF content)
21
Martone W. J., Jarvis W. R., Culver U. H., Haley R. W. Incidence and nature of endemic and epidemic nosocomial infections. In: Bennett JV, Brachman PS, eds. Hospital infections, 3rd ed. Boston: Little, Brown and Co.; 1993. 577—596.
(check this in PDF content)
22
Fagon J. Y., Chastre J., Hance A. J. et al.Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Amer. J. Med. 1993; 94 (3): 281—288.
(check this in PDF content)
23
Leu H. S., Kaiser D. L., Mori M. et al.Hospital-acquired pneumonia: attributable mortality and morbidity. Amer J Epidemiol 1989; 129 (6): 1258—1267.
(check this in PDF content)
24
Kollef M. H., Ward S.The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilatorassociated pneumonia. Chest 1998; 113 (2): 412—420.
(check this in PDF content)
25
Edmondson E. B., Reinarz J. A., Pierce A. K., Sanford J. P.Nebulization equipment: a potential source of infection in gram-negative pneumonia's. Amer. J. Dis. Child 1966; 111 (4): 357—360.
(check this in PDF content)
26
Kollef M. H.Ventilator-associated pneumonia: the importance of initial empirical antibiotic selection. Infect. Med. 2000; 17 (4): 265—268, 278—283. Поступила 28.09.09 Рецензия на монографию Э. В. Недашковского «Опера
(check this in PDF content)